- Home
- BMRA vs SNGX Comparison
BMRA vs SNGX Comparison
Compare BMRA & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- SNGX
- Stock Information
- Founded
- BMRA 1971
- SNGX 1987
- Country
- BMRA United States
- SNGX United States
- Employees
- BMRA N/A
- SNGX N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- SNGX Health Care
- Exchange
- BMRA Nasdaq
- SNGX Nasdaq
- Market Cap
- BMRA 8.1M
- SNGX 6.5M
- IPO Year
- BMRA N/A
- SNGX 1987
- Fundamental
- Price
- BMRA $3.09
- SNGX $1.37
- Analyst Decision
- BMRA
- SNGX
- Analyst Count
- BMRA 0
- SNGX 0
- Target Price
- BMRA N/A
- SNGX N/A
- AVG Volume (30 Days)
- BMRA 26.1K
- SNGX 147.3K
- Earning Date
- BMRA 04-14-2025
- SNGX 08-08-2025
- Dividend Yield
- BMRA N/A
- SNGX N/A
- EPS Growth
- BMRA N/A
- SNGX N/A
- EPS
- BMRA N/A
- SNGX N/A
- Revenue
- BMRA $5,678,000.00
- SNGX $2,342.00
- Revenue This Year
- BMRA N/A
- SNGX N/A
- Revenue Next Year
- BMRA N/A
- SNGX N/A
- P/E Ratio
- BMRA N/A
- SNGX N/A
- Revenue Growth
- BMRA 5.01
- SNGX N/A
- 52 Week Low
- BMRA $1.93
- SNGX $1.31
- 52 Week High
- BMRA $10.16
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- BMRA 45.39
- SNGX 23.71
- Support Level
- BMRA $3.03
- SNGX $1.31
- Resistance Level
- BMRA $3.44
- SNGX $1.95
- Average True Range (ATR)
- BMRA 0.19
- SNGX 0.07
- MACD
- BMRA 0.01
- SNGX -0.05
- Stochastic Oscillator
- BMRA 43.24
- SNGX 9.56
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).